Translation News and Research

RSS

U.S. Department of Defense OTT initiative to replace scars and defects with healthy, functional tissues

A two-year, $12 million contract with the U.S. Department of Defense Office of Technology Transition (OTT) will jumpstart human trials of three innovative research programs that aim to replace scars and defects with healthy, functional tissues, announced officials of the University of Pittsburgh and the McGowan Institute for Regenerative Medicine today at the Institute's Second Annual Open Session, Soldiers and Sailors Memorial Hall, Oakland.

31 May 2010

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fourth fiscal quarter and full year ended March 31, 2010. The results were highlighted by continued strong U.S. sales growth for Macroplastique and a reduction in operating and net loss compared to the prior year.

28 May 2010

G8 summit recommendations: Funding and resources for maternal, child health must be increased

Governments and other organizations must intensify efforts to improve the health of women and children, particularly in the developing world where the lion's share of deaths occur, says Dr. Philip Baker, an internationally renowned medical researcher in obstetrics & gynecology. Baker is the lead author on a G8 positioning paper that included consultations with 20 of the world's leading medical experts on women and children's health.

27 May 2010

Research work holds promise for biological substitute for dental implants

A technique pioneered in the Tissue Engineering and Regenerative Medicine Laboratory of Dr. Jeremy Mao, the Edward V. Zegarelli Professor of Dental Medicine at Columbia University Medical Center, can orchestrate stem cells to migrate to a three-dimensional scaffold infused with growth factor, holding the translational potential to yield an anatomically correct tooth in as soon as nine weeks once implanted.

24 May 2010

Promosome signs technology license and partnership agreement with Recopharma AB of Stockholm

Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.

19 May 2010

Exiqon first-quarter revenue increases 29% to record DKK 20.7M

Reported figures are for the full reporting period unless otherwise stated. Figures for the comparable reporting period last year are stated in parenthesis after realized figures. Comparative numbers in the statement of comprehensive income do not include numbers from discontinued operations. Comparative numbers in the statement of financial position include numbers from the discontinued operations.

19 May 2010

New test to detect HBV receives regulatory approval for use in the European Union

An inexpensive new test for the detection of Hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accurate results while-you-wait, enabling doctors to take immediate action on health decisions.

19 May 2010

Cincinnati Children's Hospital Medical Center launches REGID

A new nationwide registry will allow researchers to conduct larger, more effective studies of often misdiagnosed disorders that affect thousands of children in the United States.

19 May 2010

HHS announces $1 billion in Recovery Act awards for construction, repair and renovation of research facilities

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced one billion dollars of American Recovery and Reinvestment Act funds have been awarded to construct, repair and renovate scientific research laboratories and related facilities across the country. The National Institutes of Health (NIH) National Center for Research Resources (NCRR) administered the grants, which are expected to create or sustain jobs nationwide and to help foster scientific advances that may lead to improved human health.

15 May 2010

Health reform implementation issues: Emergency room costs, consumer websites and small business questions

Kaiser Health News: The new health reform law guarantees insurance companies must cover emergency care for their beneficiaries at hospitals in- or out-of-network at the same rate. "The law also bars health plans from requiring prior authorization for emergency services. And it mandates that plans follow the 'prudent layperson' rule.

14 May 2010

Prescription drug instructions often lost in translation

Chicago Tribune: "Pharmacies that print prescription labels translated into Spanish often issue inaccurate or confusing instructions that could be potentially hazardous to a patient's health, according to a report in the May issue of Pediatrics journal."

13 May 2010

Cardiome Pharma records $15.5M net income for first-quarter 2010

Cardiome Pharma Corp. today reported financial results for the first quarter ended March 31, 2010. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).

12 May 2010

USP panel recommends to establish universal standards for prescription medication labels

To promote the establishment of universal standards for prescription medication labels-and to address the widespread problem of patient misinterpretation of medication instructions-an advisory panel formed by the U.S. Pharmacopeial Convention (USP) recently issued a set of recommendations to bring consistency to labeling on dispensed prescription packaging.

11 May 2010

Progenics Pharmaceuticals reports net loss of $18.6M in first-quarter 2010

Progenics Pharmaceuticals, Inc. today announced its results of operations for the quarter ended March 31, 2010.

11 May 2010

Mice express pain through facial expressions, says study

A new study by researchers from McGill University and the University of British Columbia shows that mice, like humans, express pain through facial expressions.

10 May 2010

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Neurological Disorders and Stroke (NINDS) are launching a five-year, $7.5 million natural history study of Duchenne muscular dystrophy (Duchenne), a degenerative genetically-linked neuromuscular disease. The study aims to validate non-invasive approaches to monitor the progression and treatment of Duchenne, and holds potential to facilitate the development of promising new therapies for people with the disease.

10 May 2010

Researchers study link between cognitive impairment and adherence problems among HF patients

Surviving heart failure calls for lifestyle changes, taking medications and following doctor's orders. Some of the 5 million heart failure patients have trouble adhering to these changes and end up returning to the hospital.

10 May 2010

Consumer Reports Health lays out next steps for consumers in variety of situations

With health reform now the law of the land, Consumer Reports Health lays out next steps for consumers in a variety of situations - those who are currently insured; Medicare and Medicaid recipients; people with pre-existing conditions; parents of children with pre-existing conditions; parents of uninsured young adults; and people who develop serious illnesses.

4 May 2010

Researchers receive $250,000 to study inventive cell-transfer therapy to treat cortical dysplasia

University of Florida researchers will receive $250,000 to study an inventive cell-transfer therapy to treat cortical dysplasia, a condition where the brain develops abnormally before birth, causing severe epilepsy in children and adults.

4 May 2010

Mylan first-quarter total revenues increase 7% to $1.29 billion

Mylan Inc. today announced its financial results for the three months ended March 31, 2010.

30 Apr 2010

Translation News and Research

U.S. Department of Defense OTT initiative to replace scars and defects with healthy, functional tissues

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

G8 summit recommendations: Funding and resources for maternal, child health must be increased

Research work holds promise for biological substitute for dental implants

Promosome signs technology license and partnership agreement with Recopharma AB of Stockholm

Exiqon first-quarter revenue increases 29% to record DKK 20.7M

New test to detect HBV receives regulatory approval for use in the European Union

Cincinnati Children's Hospital Medical Center launches REGID

HHS announces $1 billion in Recovery Act awards for construction, repair and renovation of research facilities

Health reform implementation issues: Emergency room costs, consumer websites and small business questions

Prescription drug instructions often lost in translation

Cardiome Pharma records $15.5M net income for first-quarter 2010

USP panel recommends to establish universal standards for prescription medication labels

Progenics Pharmaceuticals reports net loss of $18.6M in first-quarter 2010

Mice express pain through facial expressions, says study

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

Researchers study link between cognitive impairment and adherence problems among HF patients

Consumer Reports Health lays out next steps for consumers in variety of situations

Researchers receive $250,000 to study inventive cell-transfer therapy to treat cortical dysplasia

Mylan first-quarter total revenues increase 7% to $1.29 billion

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News